These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14962152)

  • 1. A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease.
    Loeb MB; Molloy DW; Smieja M; Standish T; Goldsmith CH; Mahony J; Smith S; Borrie M; Decoteau E; Davidson W; McDougall A; Gnarpe J; O'DONNell M; Chernesky M
    J Am Geriatr Soc; 2004 Mar; 52(3):381-7. PubMed ID: 14962152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial.
    Molloy DW; Standish TI; Zhou Q; Guyatt G;
    Int J Geriatr Psychiatry; 2013 May; 28(5):463-70. PubMed ID: 22718435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.
    Carter JD; Valeriano J; Vasey FB
    J Rheumatol; 2004 Oct; 31(10):1973-80. PubMed ID: 15468362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.
    O'Caoimh R; Healy L; Gao Y; Svendrovski A; Kerins DM; Eustace J; Kehoe PG; Guyatt G; Molloy DW
    J Alzheimers Dis; 2014; 40(3):595-603. PubMed ID: 24496072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.
    Carter JD; Espinoza LR; Inman RD; Sneed KB; Ricca LR; Vasey FB; Valeriano J; Stanich JA; Oszust C; Gerard HC; Hudson AP
    Arthritis Rheum; 2010 May; 62(5):1298-307. PubMed ID: 20155838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary measures were a useful alternative for analyzing therapeutic clinical trial data.
    Carusone SC; Goldsmith CH; Smieja M; Loeb M
    J Clin Epidemiol; 2006 Apr; 59(4):387-92. PubMed ID: 16549261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production.
    Sinisalo J; Mattila K; Nieminen MS; Valtonen V; Syrjälä M; Sundberg S; Saikku P
    J Antimicrob Chemother; 1998 Jan; 41(1):85-92. PubMed ID: 9511041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
    Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
    Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
    Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
    J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials.
    Kong FY; Tabrizi SN; Law M; Vodstrcil LA; Chen M; Fairley CK; Guy R; Bradshaw C; Hocking JS
    Clin Infect Dis; 2014 Jul; 59(2):193-205. PubMed ID: 24729507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S
    EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and harms of doxycycline treatment for Gulf War veterans' illnesses: a randomized, double-blind, placebo-controlled trial.
    Donta ST; Engel CC; Collins JF; Baseman JB; Dever LL; Taylor T; Boardman KD; Kazis LE; Martin SE; Horney RA; Wiseman AL; Kernodle DS; Smith RP; Baltch AL; Handanos C; Catto B; Montalvo L; Everson M; Blackburn W; Thakore M; Brown ST; Lutwick L; Norwood D; Bernstein J; Bacheller C; Ribner B; Church LW; Wilson KH; Guduru P; Cooper R; Lentino J; Hamill RJ; Gorin AB; Gordan V; Wagner D; Robinson C; DeJace P; Greenfield R; Beck L; Bittner M; Schumacher HR; Silverblatt F; Schmitt J; Wong E; Ryan MA; Figueroa J; Nice C; Feussner JR;
    Ann Intern Med; 2004 Jul; 141(2):85-94. PubMed ID: 15262663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial.
    Geisler WM; Koltun WD; Abdelsayed N; Burigo J; Mena L; Taylor SN; Batteiger BE; Thurman AR; Hook EW; Vaughn TA; Annett MP; Muenzen RA; Caminis J
    Clin Infect Dis; 2012 Jul; 55(1):82-8. PubMed ID: 22431798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
    Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
    JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.